ChemicalBook > CAS DataBase List > Ulocuplumab

Ulocuplumab

Product Name
Ulocuplumab
CAS No.
1375830-34-4
Chemical Name
Ulocuplumab
Synonyms
Ulocuplumab;BMS 936564|||MDX 1338;Ulocuplumab (anti-CXCR4);Research Grade Ulocuplumab;Research Grade Ulocuplumab(DHF39901)
CBNumber
CB08080897
Formula Weight
0
MOL File
Mol file
More
Less

Ulocuplumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Ulocuplumab Chemical Properties,Usage,Production

Uses

Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models[1][2].

in vivo

Ulocuplumab (3-30 mg/kg; i.p.; every 3-4 days for 5 doses; 65 days in total) inhibits tumor growth of multiple myeloma xenograft models in mice, including Ramos B cells, HL-60 cells, MOLP-8 cells, Nomo-1 cells, and JJN-3R cells models[1].

Animal Model:Severe combined immunodeficient (SCID) mice of AML model (MOLP-8 cells)[1]
Dosage:3-30 mg/kg
Administration:Intraperitoneal injection; every 3-4 days for 5 doses; last for 65 days
Result:Significantly delayed mean tumor growth by 66% and 56% when compared with isotype control on day 25.

IC 50

CXCR4

References

[1] Kashyap MK, et al. Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget. 2016 Jan 19;7(3):2809-22. DOI:10.18632/oncotarget.6465
[2] Kuhne MR, et al. BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res. 2013 Jan 15;19(2):357-66. DOI:10.1158/1078-0432.CCR-12-2333

Ulocuplumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ulocuplumab Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58

1375830-34-4, UlocuplumabRelated Search:


  • Ulocuplumab
  • Research Grade Ulocuplumab(DHF39901)
  • Ulocuplumab (anti-CXCR4)
  • BMS 936564|||MDX 1338
  • Research Grade Ulocuplumab
  • 1375830-34-4